Cargando…
Mechanism of anti-remodelling action of treprostinil in human pulmonary arterial smooth muscle cells
Treprostinil is applied for pulmonary arterial hypertension (PAH) therapy. However, the mechanism by which the drug achieves its beneficial effects in PAH vessels is not fully understood. This study investigated the effects of treprostinil on PDGF-BB induced remodelling parameters in isolated human...
Autores principales: | Lambers, Christopher, Kornauth, Christoph, Oberndorfer, Felicitas, Boehm, Panja M., Tamm, Michael, Klepetko, Walter, Roth, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6211661/ https://www.ncbi.nlm.nih.gov/pubmed/30383775 http://dx.doi.org/10.1371/journal.pone.0205195 |
Ejemplares similares
-
Treprostinil inhibits proliferation and extracellular matrix deposition by fibroblasts through cAMP activation
por: Lambers, Christopher, et al.
Publicado: (2018) -
Treprostinil Reconstitutes Mitochondrial Organisation and Structure in Idiopathic Pulmonary Fibrosis Cells
por: Fang, Lei, et al.
Publicado: (2023) -
IPF-Fibroblast Erk1/2 Activity Is Independent from microRNA Cluster 17-92 but Can Be Inhibited by Treprostinil through DUSP1
por: Blumer, Sabrina, et al.
Publicado: (2021) -
Transitioning from parenteral treprostinil to inhaled treprostinil in patients with pulmonary arterial hypertension
por: Raina, Amresh, et al.
Publicado: (2013) -
Treprostinil for pulmonary hypertension
por: Skoro-Sajer, Nika, et al.
Publicado: (2008)